From: The utility of surgical lung biopsy in cancer patients with acute respiratory distress syndrome
Patient | Underlying malignancies | Operation methods | Pathological findings | Treatment alterations | Outcome |
---|---|---|---|---|---|
1 | AML, M2 types | thoracotomy | Acute leukemia with lung involvement | chemotherapy | Deceased |
2 | Diffuse large B cell lymphoma, stage IVB | thoracotomy | Interstitial pneumonitis; Pneumocystis jiroveci infection | cotrimoxazole | Survival |
3 | CML, post BMT | thoracotomy | DAD; Pneumocystis jiroveci infection | cotrimoxazole | Deceased |
4 | NSCLC, stage IIIb | thoracotomy | Intersitial pneumonitis with fibrosis | No | Deceased |
5 | ALL, post BMT | VATS | DAD, Aspergillosis infection | No | Deceased |
6 | NSCLC, stage IV | VATS | DAD; metastatic adenocarcinoma | corticosteroids and stop antibiotics | Survival |
7 | ALL | VATS | Desquamative interstitial pneumonitis | corticosteroids | Survival |
8 | Breast cancer, | thoracotomy | Interstitial pneumonitis with fibrosis | no | Survival |
9 | NSCLC, stage IV | thoracotomy | DAD, acute and organizing phase | corticosteroids and stop antibiotics | Survival |
10 | AML, M4 types | thoracotomy | Bronchopneumonia with organizing change | no | Survival |
11 | NSCLC, stage IV | VATS | Interstitial pneumonitis with organizing change | corticosteroids | Survival |
12 | Mantle cell lymphoma stage IVa | VATS | DAD, acute and organizing phase; viral inclusion bodies | corticosteroids and stop antibiotics | Survival |
13 | NHL, stage IVB | thoracotomy | DAD; Pneumocystis jiroveci infection | no | Deceased |
14 | SCLC, limited stage | VATS | DAD, acute and organizing phase | stop anti-tuberculosis agent | Deceased |
15 | Mantle cell lymphoma, stage IIIA | thoracotomy | Acute fibrosis and organizing pneumonia | corticosteroids and stop antibiotics | Survival |
16 | Diffuse large B cell lymphoma, stage IVA | VATS | DAD, acute and organizing phase | corticosteroids and stop antibiotics | Survival |